---
title: "R&D"
description: "CBRNe World provides those tasked with defending against CBRN and IED threats with the essential practical, scientific and political information. Access the current and previous issues of the magazine by registering as a member."
url: "https://cbrneworld.com/component/tags/tag/r-d"
date: "2026-07-30T21:47:12+00:00"
language: "en-GB"
---
Written on 30 September 2022.
## [New robotics partnership aims to shape future of safe handling of hazardous materials](https://cbrneworld.com/news/new-robotics-partnership-aims-to-shape-future-of-safe-handling-of-hazardous-materials)
Orginally published in Engineer Live
A new partnership between two robotics companies is showing the potential of the technology to shape how hazardous materials are handled safely in the future.
Thanks to a recent[... ](https://vimeo.com/redroofs/review/736193150/81000dc99e)
[](https://cbrneworld.com/news/dtra-awards-prime-contract-to-systems-planning-and-analysis-inc)
Written on 19 August 2021.
## [DTRA Awards Prime Contract to Systems Planning and Analysis, Inc.](https://cbrneworld.com/news/dtra-awards-prime-contract-to-systems-planning-and-analysis-inc)
The Defense Threat Reduction Agency (DTRA) has awarded Systems Planning and Analysis (SPA), Inc. a $185 million prime contract for Research, Development, Test and Evaluation Subject Matter Expertise Advisory and Assistance Support. SPA's responsibilities in support of the Research and
...
[](https://cbrneworld.com/news/lemelson-mit-cure-it-undergraduate-winners-a-powdered-additive-for-disinfectants)
Written on 25 June 2020.
## [Lemelson-MIT “Cure it!” Undergraduate Winners - A Powdered Additive for Disinfectants](https://cbrneworld.com/news/lemelson-mit-cure-it-undergraduate-winners-a-powdered-additive-for-disinfectants)
Jason Kang, Katherine Jin and Kevin Tyan Columbia University (New York, N.Y.) $10,000 Lemelson-MIT “Cure it!” Undergraduate Winners.
The Challenge: Outbreaks of highly contagious diseases, including Ebola in West Africa and MERS in the Middle East, occur on an annual basis, and
...
[](https://cbrneworld.com/news/start-developing-tools-to-identify-potential-cbrn-threats)
Written on 16 June 2020.
## [START developing tools to identify potential CBRN threats](https://cbrneworld.com/news/start-developing-tools-to-identify-potential-cbrn-threats)
The National Consortium for the Study of Terrorism and Responses to Terrorism (START) is creating a process to identify potential CBRN threats from non-state actors.
Advancing U.S. CWMD/CWMT Capabilities in Support of the SIGMA+ Program through Development of Anticipatory Human Social
...
[](https://cbrneworld.com/news/northwestern-team-receives-grant-to-develop-virus-deactivating-mask)
Written on 27 May 2020.
## [Northwestern Team Receives Grant to Develop Virus-Deactivating Mask](https://cbrneworld.com/news/northwestern-team-receives-grant-to-develop-virus-deactivating-mask)
Through innovation, hard work and a $200,000 grant from the National Science Foundation, a research team led by chemistry Prof. Omar Farha will work to develop a reusable, virus-deactivating face mask for healthcare workers on the frontlines of the COVID-19 pandemic.
According to a May
...
[](https://cbrneworld.com/news/zeteo-biomedical-receives-nih-award-to-develop-a-universal-nasal-flu-vaccine-in-collaboration-with-the-iowa-state-university-nanovaccine-institute)
Written on 20 May 2020.
## [Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute](https://cbrneworld.com/news/zeteo-biomedical-receives-nih-award-to-develop-a-universal-nasal-flu-vaccine-in-collaboration-with-the-iowa-state-university-nanovaccine-institute)
Zeteo Biomedical LLC, Inc., a privately held, medical device company, in collaboration with the Nanovaccine Institute at Iowa State University, has been awarded a five year NIH grant to develop a room temperature stable, universal nasal flu vaccine. Zeteo will provide nasal delivery device
...
[](https://cbrneworld.com/news/dod-awards-contracts-for-development-of-a-mobile-microreactor)
Written on 10 March 2020.
## [DOD Awards Contracts for Development of a Mobile Microreactor](https://cbrneworld.com/news/dod-awards-contracts-for-development-of-a-mobile-microreactor)
The Department of Defense has awarded three teams, BWX Technologies, Inc., Lynchburg, Virginia; Westinghouse Government Services, Washington, D.C.; and X-energy, LLC, Greenbelt, Maryland; contracts to each begin design work on a mobile nuclear reactor prototype under a Strategic Capabilities
...
[](https://cbrneworld.com/news/first-human-trial-of-monoclonal-antibody-to-prevent-malaria-opens)
Written on 29 January 2020.
## [First human trial of monoclonal antibody to prevent malaria opens](https://cbrneworld.com/news/first-human-trial-of-monoclonal-antibody-to-prevent-malaria-opens)
Story from [NIH ](https://www.nih.gov/news-events/news-releases/first-human-trial-monoclonal-antibody-prevent-malaria-opens)
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has
...
[](https://cbrneworld.com/news/block-mems-awarded-phase-iii-of-15-1-million-iarpa-contract-to-detect-explosives-drugs-and-other-threats)
Written on 28 January 2020.
## [Block MEMS Awarded Phase III of $15.1 Million IARPA Contract to Detect Explosives, Drugs and other Threats](https://cbrneworld.com/news/block-mems-awarded-phase-iii-of-15-1-million-iarpa-contract-to-detect-explosives-drugs-and-other-threats)
Block MEMS, LLC (Block) has been selected for Phase III of an Intelligence Advanced Research Projects Activity (IARPA) program for the standoff detection of trace and bulk quantities of drugs such as fentanyl, explosives, chemical warfare agents (CWAs) and toxic chemicals. Block is the only
...
[](https://cbrneworld.com/news/gsk-licenses-tuberculosis-vaccine-candidate-to-the-bill-melinda-gates-medical-research-institute-for-continued-development)
Written on 27 January 2020.
## [GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development](https://cbrneworld.com/news/gsk-licenses-tuberculosis-vaccine-candidate-to-the-bill-melinda-gates-medical-research-institute-for-continued-development)
- The M72/AS01E tuberculosis vaccine candidate demonstrated in a phase IIb trial the potential to reduce active pulmonary TB by half in adults with latent TB infection.
- Developing a new vaccine against TB is a
...
[](https://cbrneworld.com/news/dhs-s-t-to-engage-innovators-on-detection-canine-research-2)
Written on 27 November 2019.
## [ DHS S&T to Engage Innovators on Detection Canine Research](https://cbrneworld.com/news/dhs-s-t-to-engage-innovators-on-detection-canine-research-2)
Innovators, researchers and canine training experts are invited to learn about funding opportunities in the detection canine field on December 10, 2019, 8:00 a.m. to 1:00 p.m., at the ...
[](https://cbrneworld.com/news/themis-bioscience-and-cepi-announce-initiation-of-phase-1-clinical-trial-with-lassa-fever-vaccine)
Written on 29 October 2019.
## [Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine](https://cbrneworld.com/news/themis-bioscience-and-cepi-announce-initiation-of-phase-1-clinical-trial-with-lassa-fever-vaccine)
[Themis](https://cts.businesswire.com/ct/CT?id=smartlink&url=http://www.themisbio.com/#/news&esheet=52118421&newsitemid=20191029005063&lan=en-US&anchor=Themis+Bioscience&index=1&md5=b76bbc455bc1ddfb8729ede0f408a7af)
...
[](https://cbrneworld.com/news/porton-biopharma-advance-next-generation-anthrax-vaccine-to-phase-1-clinical-trial)
Written on 22 October 2019.
## [Porton Biopharma Advance Next Generation Anthrax Vaccine to Phase 1 Clinical Trial](https://cbrneworld.com/news/porton-biopharma-advance-next-generation-anthrax-vaccine-to-phase-1-clinical-trial)
[Porton Biopharma](https://www.portonbiopharma.com/) Ltd (PBL) has today announced that it has signed a modification to its contract (HHSN272201600045C) with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases
...
[](https://cbrneworld.com/news/hhs-explores-lung-on-a-chip-technology-in-developing-chemical-injury-treatments)
Written on 09 October 2019.
## [HHS Explores Lung-on-a-Chip Technology in Developing Chemical Injury Treatments](https://cbrneworld.com/news/hhs-explores-lung-on-a-chip-technology-in-developing-chemical-injury-treatments)
The U.S. Department of Health and Human Services (HHS) will support tests of organ-on-a-chip technology to determine how it can be used to understand injuries caused by inhaled chlorine gas, a potential national security threat, and to develop treatments for those injuries.
The
...
[](https://cbrneworld.com/news/sabin-vaccine-institute-receives-award-to-develop-develop-ebola-sudan-and-marburg-vaccines)
Written on 04 October 2019.
## [Sabin Vaccine Institute Receives Award to Develop Develop Ebola Sudan and Marburg Vaccines](https://cbrneworld.com/news/sabin-vaccine-institute-receives-award-to-develop-develop-ebola-sudan-and-marburg-vaccines)
The Sabin Vaccine Institute (Sabin) has announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Under the terms of this agreement,
...
[](https://cbrneworld.com/news/research-developing-sensors-for-worm-robots-to-be-used-after-disasters)
Written on 04 October 2019.
## [Research developing sensors for ‘worm robots’ to be used after disasters ](https://cbrneworld.com/news/research-developing-sensors-for-worm-robots-to-be-used-after-disasters)
Researchers from The University of Manchester are developing chemical sensors that can be mounted on to ‘worm robots’, as part of a project involving partners in four European countries to improve detection of people trapped under debris after a disaster.
In the face of natural or
...
[](https://cbrneworld.com/news/llnl-nerve-agent-antidote-shows-great-potential)
Written on 17 September 2019.
## [LLNL Nerve Agent Antidote Shows Great Potential ](https://cbrneworld.com/news/llnl-nerve-agent-antidote-shows-great-potential)
Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02.
Their work has been showing great promise, and with somw refinement of
...
[](https://cbrneworld.com/news/ebola-bombali-detected-in-guinea)
Written on 14 September 2019.
## [Ebola Bombali Detected in Guinea](https://cbrneworld.com/news/ebola-bombali-detected-in-guinea)
Researchers from The University of California, Davis, have recenctly publsihed their findings regarding the discovery of the sitxth ebolavirus, Bombali, in Angolan free-tailed bats roosting inside people’s houses in Guéckedou and Kissidougou, Guinea.
The team from UC
...
[](https://cbrneworld.com/news/nuclear-forensics)
Written on 05 September 2019.
## [Nuclear Forensics](https://cbrneworld.com/news/nuclear-forensics)
Scientists at the [Lawrence Livermore National Laboratory (LLNL) ](https://www.llnl.gov)have been conducting some interesting research, going down to the microscale to study diverse characteristics of nuclear fuel pellets. This is
...
[](https://cbrneworld.com/news/pluristem-and-u-s-dod-present-positive-data-from-studies-testing-plx-r18-as-a-prophylactic-treatment-for-ars)
Written on 31 July 2019.
## [Pluristem and U.S. DOD Present Positive Data from Studies Testing PLX-R18 as a Prophylactic Treatment for ARS](https://cbrneworld.com/news/pluristem-and-u-s-dod-present-positive-data-from-studies-testing-plx-r18-as-a-prophylactic-treatment-for-ars)
[Pluristem Therapeutics Inc](http://www.pluristem.com/). a leading regenerative medicine company developing novel placenta-based cell therapy products is presenting positive results from a series of studies of the company’s PLX-R18 cell therapy product
...
[](https://cbrneworld.com/news/a-dose-of-inner-strength-to-survive-and-recover-from-potentially-lethal-health-threats)
Written on 29 July 2019.
## [A Dose of Inner Strength to Survive and Recover from Potentially Lethal Health Threats](https://cbrneworld.com/news/a-dose-of-inner-strength-to-survive-and-recover-from-potentially-lethal-health-threats)
**New tools for programmable modulation of gene expression could yield enhanced resilience against influenza and ionizing radiation for service members and first responders.**
Breakthroughs in the science of programmable gene expression inspired DARPA to ...
[](https://cbrneworld.com/news/biology-professor-receives-1-9-million-grant-from-nih-to-study-vaccinia-virus)
Written on 25 July 2019.
## [Biology professor receives $1.9 million grant from NIH to study Vaccinia virus](https://cbrneworld.com/news/biology-professor-receives-1-9-million-grant-from-nih-to-study-vaccinia-virus)
Zhilong Yang, an assistant professor in the Division of Biology, is the principal investigator on a new, nearly $1.9 million grant from the National Institutes of Health. The five-year project will study how vaccinia virus — a member of the poxvirus family — produces its proteins. This award is
...
[](https://cbrneworld.com/news/cepi-awards-up-to-us-23-4-million-to-valneva-for-late-stage-development-of-a-single-dose-chikungunya-vaccine)
Written on 25 July 2019.
## [CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine](https://cbrneworld.com/news/cepi-awards-up-to-us-23-4-million-to-valneva-for-late-stage-development-of-a-single-dose-chikungunya-vaccine)
Valneva SE (“Valneva”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition for Epidemic Preparedness Innovations (CEPI) hereby announce a new partnering agreement.
With support from the European Union’s (EU’s)
...
[](https://cbrneworld.com/news/inovio-receives-8-14-million-towards-development-of-its-commercial-skin-delivery-device)
Written on 11 June 2019.
## [Inovio Receives $8.14 Million Towards Development of its Commercial Skin Delivery Device](https://cbrneworld.com/news/inovio-receives-8-14-million-towards-development-of-its-commercial-skin-delivery-device)
Inovio Pharmaceuticals, Inc.has announced that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical CBRN Defense Consortium will provide $8.14 million to support Inovio in
...
[](https://cbrneworld.com/news/ology-bioservices-wins-two-dod-awards-totalling-more-than-135-million)
Written on 16 April 2019.
## [Ology Bioservices Wins Two DOD Awards Totalling More Than $135 Million](https://cbrneworld.com/news/ology-bioservices-wins-two-dod-awards-totalling-more-than-135-million)
Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts
...
[](https://cbrneworld.com/news/uams-researcher-gets-1-86m-to-study-poxvirus)
Written on 16 April 2019.
## [UAMS researcher gets $1.86M to study poxvirus](https://cbrneworld.com/news/uams-researcher-gets-1-86m-to-study-poxvirus)
The poxvirus — with its applications for the investigation of disease development, cross-species infection-caused diseases, vaccine development and cancer virotherapy — is the focus of research by Jia Liu, Ph.D., who has received a $1.86 million grant from the National Institutes of Health to
...
[](https://cbrneworld.com/news/snapshot-s-t-taps-open-innovation-to-identify-new-tools-to-combat-the-opioid-crisis)
Written on 15 April 2019.
## [Snapshot: S&T taps open innovation to identify new tools to combat the opioid crisis](https://cbrneworld.com/news/snapshot-s-t-taps-open-innovation-to-identify-new-tools-to-combat-the-opioid-crisis)
The opioid crisis has devastated communities across the country, creating an unprecedented public health crisis. The Centers for Disease Control and Prevention (CDC) just released a [new](https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf)
...
[](https://cbrneworld.com/news/24-5-million-to-develop-vaccines-and-therapies-for-nipah-and-hendra-viruses)
Written on 26 March 2019.
## [$24.5 million to develop vaccines and therapies for Nipah and Hendra viruses](https://cbrneworld.com/news/24-5-million-to-develop-vaccines-and-therapies-for-nipah-and-hendra-viruses)
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), along with Uniformed Services University of the Health Sciences (USU), Profectus Biosciences, Inc., the Vanderbilt University Medical Center, Mapp Biopharmaceutical, Inc., and
...
[](https://cbrneworld.com/news/darpa-launches-social-media-platform-to-accelerate-r-d)
Written on 22 March 2019.
## [DARPA Launches Social Media Platform to Accelerate R&D](https://cbrneworld.com/news/darpa-launches-social-media-platform-to-accelerate-r-d)
DARPA aims to apply the power of social networks to research and development via a novel social media platform purpose-built to quicken the pace of U.S. technology development. Polyplexus, which was recently launched as a public platform, is designed to increase access to scientific
...
## Schema
```json
{ "@context": "https://schema.org", "@type": "Organization", "@id": "https://cbrneworld.com/component/tags/tag/r-d#organization", "name": "CBRNe World Magazine", "description": "CBRNe World provides those tasked with defending against CBRN and IED threats with the essential practical, scientific and political information. Access the current and previous issues of the magazine by registering as a member.", "email": "enquiries@cbrneworld.net", "url": "https://cbrneworld.com", "telephone": "+447504613126", "logo": "https://cbrneworld.com/images/default/Asset%201.png", "image": "https://cbrneworld.com/images/default/Asset%201.png", "address": { "@type": "PostalAddress", "streetAddress": "3a Upper High Street", "addressCountry": "GB", "addressLocality": "Winchester", "addressRegion": "Hampshire", "postalCode": "SO23 8UT" }, "sameAs": [ "https://www.facebook.com/cbrneworld", "https://twitter.com/cbrneworld", "https://www.linkedin.com/company/cbrne-world", "https://www.youtube.com/@TheRealCBRNeWorld" ] }
```
```json
{ "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "R&D", "item": "https://cbrneworld.com/component/tags/tag/r-d" } ] }
```